Medifast, Inc.
| Security | MED / Medifast, Inc. |
| Insider | Maloney James P. |
This page shows the track record and history of Maloney James P.
insider trades in Medifast, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Maloney James P. in MED / Medifast, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Maloney James P. in MED / Medifast, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-25 | 4 | Maloney James P. | MED | Common Stock | D | 1,014 | 73,033 | ||||||
| 2026-03-27 | 2026-03-25 | 4 | Maloney James P. | MED | Common Stock | D | 34,344 | 72,019 | ||||||
| 2026-03-27 | 2026-03-25 | 4 | Maloney James P. | MED | Common Stock | D | 9.5900 | -3,224 | -31 | 37,675 | ||||
| 2026-03-27 | 2026-03-17 | 4 | Maloney James P. | MED | Common Stock | D | 10.0500 | -482 | -5 | 40,899 | ||||
| 2026-03-27 | 2026-03-13 | 4 | Maloney James P. | MED | Common Stock | D | 9.6200 | -918 | -9 | 41,381 | ||||
| 2025-03-27 | 2025-03-25 | 4 | Maloney James P. | MED | Common Stock | D | 24,161 | 42,299 | ||||||
| 2025-03-18 | 2025-03-17 | 4 | Maloney James P. | MED | Common Stock | D | 14.3500 | -438 | -6 | 18,138 | ||||
| 2025-03-18 | 2025-03-16 | 4 | Maloney James P. | MED | Common Stock | D | 13.9400 | -123 | -2 | 18,576 | ||||
| 2025-03-18 | 2025-03-13 | 4 | Maloney James P. | MED | Common Stock | D | 13.8700 | -835 | -12 | 18,699 | ||||
| 2024-03-19 | 2024-03-15 | 4 | Maloney James P. | MED | Common Stock | D | 36.6100 | -424 | -16 | 19,534 | ||||
| 2024-03-19 | 2024-03-15 | 4 | Maloney James P. | MED | Common Stock | D | 36.6100 | -119 | -4 | 19,958 | ||||
| 2024-03-19 | 2024-03-15 | 4 | Maloney James P. | MED | Common Stock | D | 36.6100 | -73 | -3 | 20,077 | ||||
| 2024-03-15 | 2024-03-13 | 4 | Maloney James P. | MED | Common Stock | D | 8,718 | 20,150 | ||||||
| 2024-02-16 | 2024-02-14 | 4 | Maloney James P. | MED | Common Stock | D | 52.6800 | -648 | -34 | 11,432 | ||||
| 2024-02-16 | 2024-02-14 | 4 | Maloney James P. | MED | Common Stock | D | 2,328 | 12,080 | ||||||
| 2023-07-24 | 2023-07-20 | 4 | Maloney James P. | MED | Common Stock | D | 94.5000 | -1,027 | -97 | 9,752 | ||||
| 2023-07-24 | 2023-07-20 | 4 | Maloney James P. | MED | Common Stock | D | 3,574 | 10,779 | ||||||
| 2023-07-24 | 2023-07-20 | 4 | Maloney James P. | MED | Common Stock | D | 94.5000 | -115 | -11 | 7,205 | ||||
| 2023-05-01 | 2023-03-17 | 4 | Maloney James P. | MED | Common Stock | D | 4,574 | 7,320 | ||||||
| 2023-05-01 | 2023-03-17 | 4 | Maloney James P. | MED | Common Stock | D | 102.7500 | -75 | -8 | 2,746 | ||||
| 2023-05-01 | 2023-03-16 | 4 | Maloney James P. | MED | Common Stock | D | 104.4600 | -123 | -13 | 2,821 | ||||
| 2022-07-22 | 2022-07-20 | 4 | Maloney James P. | MED | Common Stock | D | 174.4400 | -115 | -20 | 2,944 | ||||
| 2022-03-21 | 2022-03-17 | 4 | Maloney James P. | MED | Common Stock | D | 180.5200 | -75 | -14 | 3,059 | ||||
| 2022-03-21 | 2022-03-16 | 4 | Maloney James P. | MED | Common Stock | D | 1,281 | 3,134 | ||||||
| 2021-07-22 | 2021-07-20 | 4 | Maloney James P. | MED | Common Stock | D | 277.0000 | -115 | -32 | 1,853 | ||||
| 2021-03-19 | 2021-03-17 | 4 | Maloney James P. | MED | Common Stock | D | 776 | 1,968 | ||||||
| 2020-07-22 | 2020-07-20 | 4 | Maloney James P. | MED | Common Stock | D | 1,192 | 1,192 |
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
